China Universal Asset Management Company’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$584K Sell
26,310
-2,909
-10% -$54.1K 0.03% 250
2026
Q1
$530K Buy
29,219
+5,946
+26% +$103K 0.04% 251
2025
Q4
$455K Sell
23,273
-1,664
-7% -$31.5K 0.04% 266
2025
Q3
$315K Buy
24,937
+2,108
+9% +$24K 0.03% 287
2025
Q2
$217K Buy
22,829
+139
+0.6% +$1.53K 0.02% 306
2025
Q1
$237K Buy
22,690
+1,115
+5% +$15.9K 0.02% 295
2024
Q4
$508K Buy
21,575
+2,265
+12% +$67K 0.05% 248
2024
Q3
$694K Buy
19,310
+7,812
+68% +$311K 0.08% 178
2024
Q2
$406K Sell
11,498
-4,075
-26% -$118K 0.06% 164
2024
Q1
$442K Buy
15,573
+8,474
+119% +$192K 0.06% 193
2023
Q4
$94.4K Buy
7,099
+5,541
+356% +$54.1K 0.02% 286
2023
Q3
$14K Buy
1,558
+794
+104% +$8.55K ﹤0.01% 322
2023
Q2
$8.6K Buy
764
+58
+8% +$684 ﹤0.01% 329
2023
Q1
$8.13K Buy
706
+176
+33% +$2.29K ﹤0.01% 320
2022
Q4
$6.14K Buy
530
+46
+10% +$532 ﹤0.01% 274
2022
Q3
$6K Buy
+484
New +$5.55K ﹤0.01% 249

Other funds holding DYN

China Universal Asset Management Company's DYN Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Dyne Therapeutics (DYN) stake by 10% in Q2 2026, selling an estimated $54.1K and leaving 26,310 shares worth $584K. The position accounts for 0.03% of the portfolio, ranked #250.

China Universal Asset Management Company first reported a position in DYN in Q3 2022 and has held it in 16 quarters since. The position peaked at $694K in Q3 2024. 141 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • China Universal Asset Management Company held 26,310 shares of Dyne Therapeutics worth $584K as of Q2 2026.
  • China Universal Asset Management Company sold 2,909 Dyne Therapeutics shares in Q2 2026, an estimated $54.1K.
  • Dyne Therapeutics made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #250 holding.
  • China Universal Asset Management Company first reported a position in Dyne Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Dyne Therapeutics position peaked at $694K in Q3 2024.
  • 141 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.